$113 Million is the total value of Velan Capital Investment Management LP's 28 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 83.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SPY | New | SPDR S&P 500 ETF TRput | $19,121,500 | – | 50,000 | +100.0% | 16.89% | – |
ADMA | Sell | ADMA BIOLOGICS INC | $15,520,000 | +21.2% | 4,000,000 | -24.1% | 13.71% | +8.0% |
IMCR | Sell | IMMUNOCORE HLDGS PLCads | $11,754,936 | -14.6% | 205,974 | -29.8% | 10.38% | -24.0% |
TELA | TELA BIO INC | $8,580,001 | +35.0% | 746,087 | 0.0% | 7.58% | +20.2% | |
HZNP | HORIZON THERAPEUTICS PUB L | $7,832,740 | +83.9% | 68,829 | 0.0% | 6.92% | +63.8% | |
LNTH | Sell | LANTHEUS HLDGS INC | $7,644,000 | -45.7% | 150,000 | -25.0% | 6.75% | -51.6% |
OPTN | Buy | OPTINOSE INC | $6,469,193 | -18.8% | 3,496,861 | +60.7% | 5.72% | -27.7% |
HRTX | New | HERON THERAPEUTICS INC | $6,250,000 | – | 2,500,000 | +100.0% | 5.52% | – |
QIPT | QUIPT HOME MEDICAL CORP | $3,768,000 | +12.9% | 800,000 | 0.0% | 3.33% | +0.6% | |
PNT | New | POINT BIOPHARMA GLOBAL INC | $3,602,251 | – | 494,136 | +100.0% | 3.18% | – |
INSP | New | INSPIRE MED SYS INC | $2,518,800 | – | 10,000 | +100.0% | 2.22% | – |
THC | New | TENET HEALTHCARE CORP | $2,439,500 | – | 50,000 | +100.0% | 2.16% | – |
CTLT | New | CATALENT INC | $2,250,500 | – | 50,000 | +100.0% | 1.99% | – |
IMTX | New | IMMATICS N.V | $2,177,500 | – | 250,000 | +100.0% | 1.92% | – |
EDSA | New | EDESA BIOTECH INC | $1,919,998 | – | 888,888 | +100.0% | 1.70% | – |
HCSG | Sell | HEALTHCARE SVCS GROUP INC | $1,527,024 | -68.4% | 127,252 | -68.2% | 1.35% | -71.9% |
JASPER THERAPEUTICS INC | $1,370,606 | -38.8% | 3,219,036 | 0.0% | 1.21% | -45.5% | ||
SGEN | New | SEAGEN INC | $1,285,100 | – | 10,000 | +100.0% | 1.14% | – |
CSU | SONIDA SENIOR LIVING INC | $1,035,400 | -23.0% | 82,832 | 0.0% | 0.92% | -31.4% | |
COLL | Buy | COLLEGIUM PHARMACEUTICAL INC | $1,031,194 | +61.1% | 44,448 | +11.2% | 0.91% | +43.5% |
RZLT | REZOLUTE INC | $828,000 | -24.5% | 400,000 | 0.0% | 0.73% | -32.8% | |
BLU | BELLUS HEALTH INC NEW | $822,000 | -22.2% | 100,000 | 0.0% | 0.73% | -30.7% | |
XENE | XENON PHARMACEUTICALS INC | $788,600 | +9.2% | 20,000 | 0.0% | 0.70% | -2.7% | |
Buy | ALIMERA SCIENCES INC | $698,511 | -39.6% | 257,753 | +13.2% | 0.62% | -46.2% | |
New | CONFORMIS INC | $684,770 | – | 206,256 | +100.0% | 0.60% | – | |
CHRS | New | COHERUS BIOSCIENCES INC | $654,232 | – | 82,605 | +100.0% | 0.58% | – |
LUMIRADX LTD | $514,285 | -11.8% | 571,428 | 0.0% | 0.45% | -21.5% | ||
TERN | New | TERNS PHARMACEUTICALS INC | $108,376 | – | 10,646 | +100.0% | 0.10% | – |
GKOS | Exit | GLAUKOS CORP | $0 | – | -6,896 | -100.0% | -0.36% | – |
Exit | NYXOAH S A | $0 | – | -79,021 | -100.0% | -0.49% | – | |
ASRT | Exit | ASSERTIO HOLDINGS INC | $0 | – | -234,766 | -100.0% | -0.53% | – |
CFMS | Exit | CONFORMIS INC | $0 | – | -5,156,406 | -100.0% | -0.98% | – |
ZYME | Exit | ZYMEWORKS INC | $0 | – | -234,902 | -100.0% | -1.43% | – |
Exit | THE ONCOLOGY INSTITUTE INC | $0 | – | -548,841 | -100.0% | -2.52% | – | |
BCRX | Exit | BIOCRYST PHARMACEUTICALS INC | $0 | – | -225,000 | -100.0% | -2.81% | – |
FEZ | Exit | SPDR INDEX SHS FDSput | $0 | – | -500,000 | -100.0% | -15.26% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LANTHEUS HLDGS INC | 8 | Q3 2023 | 18.0% |
ADMA BIOLOGICS INC | 8 | Q3 2023 | 13.7% |
JASPER THERAPEUTICS INC | 8 | Q3 2023 | 17.8% |
TELA BIO INC | 8 | Q3 2023 | 7.6% |
REZOLUTE INC | 8 | Q3 2023 | 1.3% |
OPTINOSE INC | 7 | Q3 2023 | 7.9% |
IMMUNOCORE HLDGS PLC | 6 | Q1 2023 | 13.7% |
ALIMERA SCIENCES INC | 6 | Q3 2023 | 34.0% |
QUIPT HOME MEDICAL CORP | 6 | Q3 2023 | 4.8% |
SONIDA SENIOR LIVING INC | 6 | Q1 2023 | 2.5% |
View Velan Capital Investment Management LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
SC 13G | 2024-03-28 |
13F-HR | 2024-02-14 |
4 | 2024-02-09 |
SC 13D/A | 2024-02-09 |
SC 13G/A | 2024-01-29 |
13F-HR | 2023-11-13 |
4 | 2023-10-04 |
4 | 2023-08-17 |
SC 13D/A | 2023-08-16 |
13F-HR | 2023-08-11 |
View Velan Capital Investment Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.